The first patients to receive Intellia's CRISPR-based therapy for hereditary angioedema saw their swelling attacks virtually ...

AstraZeneca is having another big ASCO, but the art of comfort care for cancer patients also got a plenary session.

When palliative care is delivered via telehealth, there are a number of advantages. They can be at home, in their pajamas, ...

At ASCO, Astra Zeneca reported that its drug Enhertu stalled the growth of tumors by more than a year in women with the most ...

The resurrection of a GSK blood cancer drug — which the company withdrew from the U.S. market not even two years ago — is ...

AstraZeneca reports at ASCO that its drug Tagrisso slowed down lung cancer progression for a median of several years in stage ...